socalTECH

JANUARY 17, 2017

San Diego-based AnaptysBio , which develops antibodies for treating inflammation, has set its estimated IPO pricing range, saying on Tuesday that it expects to price its IPO at between $14.00 The company is selling 4,000,000 shares of its common stock on the NASDAQ Global Select Market as ANAB. and $16.00

Pricing 100

Pricing Avalon Southern California Venice 100

socalTECH

NOVEMBER 14, 2013

San Diego-based medical device manufacturer Tandem Diabetes Care priced its IPO last night, saying it will offer up 8,000,000 shares of its common stock at $15.00 The company--which develops an insulin pump--will start trading today on the NASDAQ Global Market as TNDM.

Pricing 153

Pricing San Diego Startup Acquisition 153

socalTECH

MAY 16, 2013

San Diego-based Ambit Biosciences has priced its IPO, saying that it is offering up 8,125,000 shares of its common stock at $8.00 The company will start trading today on the NASDAQ Global Market as AMBI. Ambit priced well below its estimated initial public offering range, which had been set at between $13.00

Pricing 138

Pricing San Diego Startup Acquisition 138

socalTECH

JULY 25, 2012

San Diego-based Peregrine Semiconductor , the developer of CMOS, RF integrated circuits, has set an estimated pricing range for its its IPO. According to a filing by the firm this morning, it is estimating a IPO price of between $14.00 and $16.00 The firm is offering 5,500,000 shares of its stock in its IPO.

Pricing 145

Pricing San Diego Equity Marketing 145

socalTECH

SEPTEMBER 18, 2020

San Diego-based green energy technology developer Nuvve , which is developing vehicle-to-grid load balancing technology, says it has started participating in California's wholesale energy markets, via an effort with the University of California San Diego.

San Diego 124

San Diego Pricing Design Sites 124

socalTECH

AUGUST 18, 2020

San Diego-based Deposit Defender says it has launched a new app, which helps renters photo-document rental property inspections, in order to prevent future loss of their security deposits. The company said that its app--which stores that data in the cloud--also can be used by landlords to inspects and document their rental properties.

Help 203

Help San Diego Screening Pricing 203

socalTECH

JANUARY 21, 2021

San Diego- and New Jersey-based OncoSec Medical, a publicly traded biotechnology company focused on treatment of cancer, said today that it is raising $42.0M The company said it is offering of 7,711,284 shares of its common stock at a price of $5.45, with an expected close on January 25th.

San Diego 113

San Diego Activity Research Pricing 113

socalTECH

AUGUST 16, 2021

San Diego-based sales and marketing software developer Seismic has raised $170M in a Series G funding round, the company said this morning, and is now valued at $3 billion. Rowe Price, according to the company. Rowe Price, according to the company. Seismic has now raised $440M in total funding.

San Diego 113

San Diego Coach Sales Training 113

socalTECH

MARCH 15, 2021

San Diego-based Longboard Pharmaceuticals, which is developing medicines for neurological diseases, raised $80M in its IPO last week, selling 5,000,000 shares of its common stock at a price of $16.00 The company is now trading on the Nasdaq Global Market as LBPH.

San Diego 113

San Diego Pricing Design Marketing 113

socalTECH

FEBRUARY 26, 2021

San Diego-based sales enablement software developer Seismic said this week that it has named Donna DeBerry as its new Vice President, Inclusion. According to the company, DeBerry will lead efforts to build an even more diverse, equitable, and inclusive workforce and company culture. Rowe Price.

Southern California 113

Southern California San Diego Software Development Pricing 113

socalTECH

OCTOBER 9, 2020

San Diego-based sales enablement and marketing software developer Seismic said this week that it has named a new Chief Product Officer. Seismic said it has named Krish Mantipragada as its new Chief Product Officer, joining the company from Medallia, where he also was Chief Product Officer and an Executive Vice President.

Product 124

Product Southern California San Diego Sales 124

socalTECH

APRIL 8, 2019

San Diego-based Guardion Health Sciencs , which is developing "condition-specific medical foods and testing technologies" for the ocular health market, has raised $5.0M The company priced its IPO on Friday, selling 1,250,000 shares of its common stock at a price of $4.00 in a small IPO. READ MORE>>.

San Diego 113

San Diego Pricing Capital Marketing 113

TechCrunch LA

MARCH 22, 2018

The Alliance estimates that Southern California’s tech community could be one-third the size of Silicon Valley’s by supporting or further developing the six pillars it already has for innovation to occur.

Southern California 224

Southern California Dollar Shave Club SoCal Develop 224

socalTECH

SEPTEMBER 10, 2020

San Diego-based sales enablement and marketing software developer Seismic said this morning that it has named Heather Cole as the company Vice President, Market Growth. Cole was previously VP and Research Director at Forrester-SiriusDecisions. Seismic is venture backed by Lightspeed Venture Partners, T. READ MORE>>.

San Diego 113

San Diego Equity Research Software Development 113

socalTECH

JUNE 3, 2020

San Diego-based Evofem Biosciences , a publicly held, biopharmaceuticals company which is developing products in the area of women's sexual and reproductive health, says it has priced approximately $100M in common stock to the public.

San Diego 113

San Diego Pricing Product Develop 113

TechCrunch LA

FEBRUARY 6, 2022

The Facebook parent-company saw its stock price get bludgeoned after a bad earnings report showcased that Apple’s ad-blocking changes are shaving billions off its books and the company’s crown jewel — the Facebook platform — has stopped growing and actually shrank this quarter.

Marketing 246

Marketing Newsletter Technical Review News 246

socalTECH

JANUARY 27, 2021

San Diego-based Design Therapeutics, a biotech company which is developing small molecules for the treatment of serious degenerative disorders caused by inherited nucleotide repeat expansions, said it has raised $125M in its Series B funding round. Rowe Price Associates, Inc., Arsani William, M.D.,

Design 113

Design San Diego Capital Pricing 113

socalTECH

JULY 8, 2020

San Diego-based biopharmaceuticals developer VelosBio says it has raised $137M in a Series B funding roudn, to go towards its oncology efforts. Rowe Price Associates, Inc., Venrock Healthcare Capital Partners, Viking Global Investors, Wellington Management Company, as well as the company's existing investors.

San Diego 113

San Diego Class Capital Pricing 113

socalTECH

MAY 28, 2019

San Diego-based Cibus , a developer of gene editing tools being aimed at use in plant breeding, has pulled its IPO paperwork, saying in a filing that it has decided "not to proceed with the initial public offering of its securities at this time." Cibus had set an estimated initial pricing range of $14.00 READ MORE>>.

San Diego 113

San Diego Pricing Tool Invest 113

Xconomy

AUGUST 11, 2020

Ligand Pharmaceuticals plans to acquire recombinant protein therapeutics maker Pfenex for $438 million, the companies announced Monday. The larger company agreed to pay $12 per share for Pfenex (NYSE American: PFNX )—a 57 percent premium to its closing price Monday. The company reported revenues of about $120.3

San Diego 98

San Diego Technology Research Pricing 98

socalTECH

SEPTEMBER 17, 2018

San Diego-based Senomyx , a developer of artificial flavoring ingredients and sweeteners for the beverage and food market, has been acquired by Switzerland's Firmenich , in a deal worth approximately $72.5M. According to the two companies, Firmenich will acquire all of the outstanding common stock of SEnomyx for $1.50

San Diego 113

San Diego Pricing Marketing Develop 113

Xconomy

JULY 8, 2020

Dave Johnson has known UC San Diego physician and cancer reseacher Thomas Kipps for nearly 20 years. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 121

San Diego Develop Development UCSD 121

socalTECH

OCTOBER 28, 2020

San Diego-based Arena Pharmaceuticals announced this morning that it has launched a new company, Longboard Pharmaceuticals , with $56M in funding. According to Areana, the newly launched company will focus on investigational therapies for rare neurological diseases.

Funding 113

Funding San Diego Pricing Capital 113

socalTECH

DECEMBER 22, 2017

San Diego-based precision medicine developer Ignyta has agreed to be acquired by biopharmaceuticals giant Roche , in a $1.7 The companies said the price is a premium of 74% on Ignyta's closing price on Thursday. The companies said the price is a premium of 74% on Ignyta's closing price on Thursday.

San Diego 113

San Diego Pricing Develop Development 113

socalTECH

SEPTEMBER 29, 2020

San Diego-based Seismic , which develops sales enablement and marketing software, has joined the unicorn club, saying this morning that it has raised $92M in a Series F funding, which values the company at approximately $1.6 Rowe Price, its existing investors. Seismic has now raised a total of $270M in funding.

San Diego 113

San Diego Sales Pricing Activity 113

socalTECH

APRIL 14, 2017

San Diego-based gene therapy developer Tocagen rose in its IPO this morning, after pricing at $10.00 Tocagen is developing clinical-stage, cancer-selective gene therapy products. Tocagen is developing clinical-stage, cancer-selective gene therapy products. per share last night in its initial public offering.

San Diego 127

San Diego Pricing Marketing Product 127

socalTECH

NOVEMBER 4, 2010

San Diego-based Zogenix has updated its S-1, saying this morning the firm intends to offer 6 million shares of its common stock on the Nasdaq Global Market as ZGNX. The firm also said it currently estimates the firm's initial offering price at between $12.00 and $14.00 Zogenix had filed for an IPO in September. READ MORE>>.

Pricing 140

Pricing San Diego Acquisition Marketing 140

socalTECH

SEPTEMBER 23, 2019

A portfolio company of San Diego-based biopharmaceuticals venture investor Versant Ventures is getting set for its IPO this week. Aprea Therapeutics said that estimates its IPO will price between $14.00 and $16.00 per share, which could raise as much as $92.0M for the biotech. Versant owns around 17.73 READ MORE>>.

San Diego 113

San Diego Pricing Invest Marketing 113

socalTECH

AUGUST 29, 2018

San Diego-based Obalon Therapeutics , a publicly held developer of medical devices to treat obesity, has raised $10M in a private placement, the company said this week. The company said it 5,494,506 shares of common stock at a price of $1.82 per share in the offering. Obalon trades on the NASDAQ as OBLN.

San Diego 100

San Diego Pricing Invest Funding 100

socalTECH

NOVEMBER 5, 2019

CrowdStrike , the developer of endpoint protection software and cybersecurity tools with a big presence in Orange County, is extending its software to Amazon Web Services, the company said today. The company said its software provides a single agent running on a node, which protects all of the containers running on that node.

Orange County 113

Orange County EC2 San Diego Web 113

socalTECH

OCTOBER 10, 2019

San Diego-based Mercato , which provides delivery of items from independently owned grocery and specialty food stores, has launched a new program that offers up unlimited free, same-day grocery delivery from local grocery stores. Mercato is led by founder and CEO Bobby Brannigan. Mercato is led by founder and CEO Bobby Brannigan.

San Diego 113

San Diego Pricing Funding Invest 113

socalTECH

SEPTEMBER 8, 2014

San Diego-based Anametrix , which develops marketing analytics software, said Monday that it has tied its software to Tableau , the developer of visual data analytics tools. Price of the new product was not announced. Anametrix is led by Pelin Thorogood. READ MORE>>.

San Diego 178

San Diego Software Pricing Tool 178

socalTECH

NOVEMBER 27, 2017

San Diego-based Odonate Therapeutics , a startup that says it is hoping to develop chemotherapy drugs, is looking to raised $182.5M The company has set its estimated IPO price range at between $24.00 The company's IPO is being underwritten by Goldman Sachs & Co., and $27.00 Jeffries, and Cowen.

San Diego 113

San Diego Pricing Capital Funding 113

socalTECH

AUGUST 25, 2016

San Diego-based biopharmaceutiacls developer Viking Therapeutics says it has raised $12.5M The company, which is publicly traded on the NASDAQ as VKTX, said the initial purchase came at $1.50 per share, with the remaining $12M to be purchase over the next 30 months at prices based on the market price.

San Diego 100

San Diego Pricing Capital Funding 100

Xconomy

MAY 22, 2020

But the biotech sector is defying the pandemic with crossover financings and freshly minted public companies. On Friday, three firms added their names to the list of life science companies preparing to join the public markets.

Company 145

Company Companies Marketing Develop 145

socalTECH

SEPTEMBER 3, 2014

San Diego-based biopharmaceuticals developer Viking Therapeutics has set the estimated pricing for its IPO, saying in a filing Tuesday that it expects to price its IPO at between $10.00 The company has applied to list as VKTX on the NASDAQ Global market. The company is hoping to raise up to $69.0M

San Diego 138

San Diego Pricing Research Acquisition 138

socalTECH

MAY 20, 2013

San Diego-based security software developer Websense announced this morning that it has signed a definitive agreement to be acquired by private equity firm Vista Equity Partners. per share in cash for the company. Websense said the deal is an approximate premium of 29 percent over the firm''s Friday closing price.

Equity 159

Equity San Diego Software Development Acquisition 159